TARO PHARMACEUTICAL INDUS (TARO)

IL0010827181 - Common Stock

42.19  -0.05 (-0.12%)

After market: 42.19 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
610.85M573.00M561.30M549.00M644.80M
Minority Interest Expense
N/A0.000.0014.10M-300.00K
Cost Of Goods
317.54M304.60M268.20M252.30M245.00M
Gross Profit
293.30M268.30M293.10M296.70M399.70M
Operating Expenses
271.30M250.60M168.20M151.50M153.20M
Research and Development
60.29M52.20M54.50M60.20M59.80M
Selling, General, and Administrative Expenses
210.91M198.40M113.70M91.40M93.40M
Operating Income
22.01M17.70M125.00M145.10M246.50M
Interest Income/Expense
48.53M18.00M10.20M19.80M48.50M
Other Income/Expense
3.93M2.50M4.20M2.90M3.00M
Non Recurring Items
N/A0.00-61.50M-558.90M0.00
Income Before Taxes
74.34M38.20M77.90M-391.10M298.00M
Income Tax
28.64M12.80M19.60M9.70M53.50M
Net Income
45.61M25.40M58.30M-386.70M244.20M
EBITDA
55.68M49.80M150.90M168.80M267.90M
 
Per Share Data
EPS Diluted Total Ops
1.220.681.55-10.126.35
Non GAAP EPS
1.500.673.18-10.116.36
 
Statistics
Gross Profit Margin
48.02%46.82%52.22%54.04%61.99%
Profit Margin
7.47%4.43%10.39%-70.44%37.87%
Operating Profit Margin
3.60%3.09%22.27%26.43%38.23%

All data in USD

Charts